- Formation Bio (New York, NY)
- …will manage a team of Clinical Trial Managers (CTMs) and Clinical Research Associates (CRAs) and will collaborate closely with cross-functional teams ... industry can progress because of the high cost and time of clinical trials. Recognizing that this...research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to… more
- Merck & Co. (Rahway, NJ)
- …percent of the time to manage future or ongoing clinical research projects. QualificationsEducation:M.D or MD/Ph.D.Required:Must have experience in industry ... (Sr. Principal Scientist) has primary responsibility for the planning and directing clinical research activities involving new or marketed Oncology medicines.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.SummaryThe Director, Clinical ... Safety, will be a product safety lead or part of a product safety team, and be responsible...and provide safety leadership including but not limited to clinical studies, post-marketing surveillance, signal detection and management, important… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Chemical Engineering Research & Development department (CERD), part of the Process Research and Development organization, is seeking a ... enzyme processes that meet target yield, activity, and purity to ensure clinical and commercial drug substance needs. This individual will play a critical… more
